CH622005A5 - Process for the preparation of novel benzanilide derivatives - Google Patents

Process for the preparation of novel benzanilide derivatives Download PDF

Info

Publication number: CH622005A5
Authority: CH; Switzerland
Prior art keywords: formula; compounds; lower alkyl; compound; reaction
Prior art date: 1975-08-20

Application number

CH1054476A

Other languages

German (de)

English (en)

Inventor

Takashi Mori

Sakae Takaku

Nobuhiro Oi

Minoru Shindo

Takeaki Hirano

Shigeyuki Kataoka

Kouji Furuno

Original Assignee

Chugai Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1975-08-20

Filing date

1976-08-18

Publication date

1981-03-13

1975-08-20 Priority claimed from JP10013975A external-priority patent/JPS5225735A/ja

1975-08-25 Priority claimed from JP10209175A external-priority patent/JPS5227742A/ja

1976-08-18 Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd

1981-03-13 Publication of CH622005A5 publication Critical patent/CH622005A5/de

Links

ZVSKZLHKADLHSD-UHFFFAOYSA-N benzanilide Chemical class C=1C=CC=CC=1C(=O)NC1=CC=CC=C1 ZVSKZLHKADLHSD-UHFFFAOYSA-N 0.000 title claims abstract description 8
238000000034 method Methods 0.000 title claims description 22
238000002360 preparation method Methods 0.000 title claims description 6
150000001875 compounds Chemical class 0.000 claims abstract description 26
229910052739 hydrogen Inorganic materials 0.000 claims abstract description 6
239000001257 hydrogen Substances 0.000 claims abstract description 6
125000003545 alkoxy group Chemical group 0.000 claims abstract description 5
125000000217 alkyl group Chemical group 0.000 claims abstract description 5
230000000694 effects Effects 0.000 claims abstract description 5
125000005842 heteroatom Chemical group 0.000 claims abstract description 5
125000000623 heterocyclic group Chemical group 0.000 claims abstract description 5
125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 5
230000001077 hypotensive effect Effects 0.000 claims abstract description 3
230000002093 peripheral effect Effects 0.000 claims abstract description 3
230000000144 pharmacologic effect Effects 0.000 claims abstract description 3
125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract 3
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 38
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 12
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
238000006243 chemical reaction Methods 0.000 claims description 12
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 9
WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 9
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 7
239000011734 sodium Substances 0.000 claims description 7
229910052708 sodium Inorganic materials 0.000 claims description 7
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
239000000203 mixture Substances 0.000 claims description 6
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
241001465754 Metazoa Species 0.000 claims description 4
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 4
229910052736 halogen Inorganic materials 0.000 claims description 4
150000002367 halogens Chemical class 0.000 claims description 4
239000012312 sodium hydride Substances 0.000 claims description 4
229910000104 sodium hydride Inorganic materials 0.000 claims description 4
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 3
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 claims description 3
229910001863 barium hydroxide Inorganic materials 0.000 claims description 3
FDPIMTJIUBPUKL-UHFFFAOYSA-N dimethylacetone Natural products CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 claims description 3
239000011591 potassium Substances 0.000 claims description 3
229910052700 potassium Inorganic materials 0.000 claims description 3
229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
208000008469 Peptic Ulcer Diseases 0.000 claims description 2
230000000202 analgesic effect Effects 0.000 claims description 2
239000003795 chemical substances by application Substances 0.000 claims description 2
239000003814 drug Substances 0.000 claims description 2
230000035876 healing Effects 0.000 claims description 2
230000002265 prevention Effects 0.000 claims description 2
239000007858 starting material Substances 0.000 claims description 2
239000000126 substance Substances 0.000 claims description 2
208000025865 Ulcer Diseases 0.000 abstract description 9
150000004820 halides Chemical class 0.000 abstract 1
230000000304 vasodilatating effect Effects 0.000 abstract 1
238000004458 analytical method Methods 0.000 description 8
238000002844 melting Methods 0.000 description 8
230000008018 melting Effects 0.000 description 8
239000011541 reaction mixture Substances 0.000 description 7
231100000397 ulcer Toxicity 0.000 description 7
-1 aminopropoxy Chemical group 0.000 description 5
238000001953 recrystallisation Methods 0.000 description 5
WVUULNDRFBHTFG-UHFFFAOYSA-N 3-chloro-n,n-diethylpropan-1-amine Chemical compound CCN(CC)CCCCl WVUULNDRFBHTFG-UHFFFAOYSA-N 0.000 description 3
NYYRRBOMNHUCLB-UHFFFAOYSA-N 3-chloro-n,n-dimethylpropan-1-amine Chemical compound CN(C)CCCCl NYYRRBOMNHUCLB-UHFFFAOYSA-N 0.000 description 3
241000700159 Rattus Species 0.000 description 3
WPUJEWVVTKLMQI-UHFFFAOYSA-N benzene;ethoxyethane Chemical compound CCOCC.C1=CC=CC=C1 WPUJEWVVTKLMQI-UHFFFAOYSA-N 0.000 description 3
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
BIZWQFAZJDSDKB-UHFFFAOYSA-N N-[4-hydroxy-3-[(2-methylbenzoyl)amino]phenyl]-2-methylbenzamide Chemical compound CC1=C(C(=O)NC2=C(C=CC(=C2)NC(C2=C(C=CC=C2)C)=O)O)C=CC=C1 BIZWQFAZJDSDKB-UHFFFAOYSA-N 0.000 description 2
FRVYFJGKLPFFSO-UHFFFAOYSA-N N-[4-hydroxy-3-[(3-methylbenzoyl)amino]phenyl]-3-methylbenzamide Chemical compound CC=1C=C(C(=O)NC2=C(C=CC(=C2)NC(C2=CC(=CC=C2)C)=O)O)C=CC=1 FRVYFJGKLPFFSO-UHFFFAOYSA-N 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
229960004217 benzyl alcohol Drugs 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
239000003480 eluent Substances 0.000 description 2
150000002431 hydrogen Chemical class 0.000 description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
238000010992 reflux Methods 0.000 description 2
239000000741 silica gel Substances 0.000 description 2
229910002027 silica gel Inorganic materials 0.000 description 2
239000000243 solution Substances 0.000 description 2
239000002904 solvent Substances 0.000 description 2
210000002784 stomach Anatomy 0.000 description 2
LJQNMDZRCXJETK-UHFFFAOYSA-N 3-chloro-n,n-dimethylpropan-1-amine;hydron;chloride Chemical compound Cl.CN(C)CCCCl LJQNMDZRCXJETK-UHFFFAOYSA-N 0.000 description 1
LYHKQHLOZUTVKA-UHFFFAOYSA-N 4-chloro-n,n-dimethylbutan-1-amine Chemical compound CN(C)CCCCCl LYHKQHLOZUTVKA-UHFFFAOYSA-N 0.000 description 1
XXHMGCLDHZFDQB-UHFFFAOYSA-N COC1=C(C(=O)NC2=C(C=CC(=C2)NC(C2=C(C(=CC=C2)OC)OC)=O)O)C=CC=C1OC Chemical compound COC1=C(C(=O)NC2=C(C=CC(=C2)NC(C2=C(C(=CC=C2)OC)OC)=O)O)C=CC=C1OC XXHMGCLDHZFDQB-UHFFFAOYSA-N 0.000 description 1
QNCDFUWXCGGNTG-UHFFFAOYSA-N COC1=C(C(=O)NC2=C(C=CC(=C2)NC(C2=C(C=C(C=C2)C)OC)=O)O)C=CC(=C1)C Chemical compound COC1=C(C(=O)NC2=C(C=CC(=C2)NC(C2=C(C=C(C=C2)C)OC)=O)O)C=CC(=C1)C QNCDFUWXCGGNTG-UHFFFAOYSA-N 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
102220501443 Cytosolic iron-sulfur assembly component 3_C27N_mutation Human genes 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
241000978776 Senegalia senegal Species 0.000 description 1
208000007107 Stomach Ulcer Diseases 0.000 description 1
239000000205 acacia gum Substances 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000000654 additive Substances 0.000 description 1
SLUNEGLMXGHOLY-UHFFFAOYSA-N benzene;hexane Chemical compound CCCCCC.C1=CC=CC=C1 SLUNEGLMXGHOLY-UHFFFAOYSA-N 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
230000001814 effect on stress Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000012458 free base Substances 0.000 description 1
210000001156 gastric mucosa Anatomy 0.000 description 1
201000005917 gastric ulcer Diseases 0.000 description 1
229910000039 hydrogen halide Inorganic materials 0.000 description 1
239000012433 hydrogen halide Substances 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
PFXGQJOPAAAEQR-UHFFFAOYSA-N n-(3-benzamido-4-hydroxyphenyl)benzamide Chemical compound C1=C(NC(=O)C=2C=CC=CC=2)C(O)=CC=C1NC(=O)C1=CC=CC=C1 PFXGQJOPAAAEQR-UHFFFAOYSA-N 0.000 description 1
VXIQGLYUTAVDKG-UHFFFAOYSA-N n-[4-hydroxy-3-[(2-methoxybenzoyl)amino]phenyl]-2-methoxybenzamide Chemical compound COC1=CC=CC=C1C(=O)NC1=CC=C(O)C(NC(=O)C=2C(=CC=CC=2)OC)=C1 VXIQGLYUTAVDKG-UHFFFAOYSA-N 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
238000013222 sprague-dawley male rat Methods 0.000 description 1
239000012258 stirred mixture Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000036269 ulceration Effects 0.000 description 1
238000005303 weighing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

CH1054476A 1975-08-20 1976-08-18 Process for the preparation of novel benzanilide derivatives CH622005A5 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP10013975A JPS5225735A (en)	1975-08-20	1975-08-20	Preparation of benzanilide derivatives
JP10209175A JPS5227742A (en)	1975-08-25	1975-08-25	Preparation of benzanilide derivatives

Publications (1)

Publication Number	Publication Date
CH622005A5 true CH622005A5 (en)	1981-03-13

Family

ID=26441220

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CH1054476A CH622005A5 (en)	1975-08-20	1976-08-18	Process for the preparation of novel benzanilide derivatives

Country Status (5)

Country	Link
AR (1)	AR210153A1 (cs)
CH (1)	CH622005A5 (cs)
CS (1)	CS189026B2 (cs)
MX (1)	MX3756E (cs)
NL (1)	NL7609208A (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995026328A1 (en) *	1994-03-26	1995-10-05	Smithkline Beecham Plc	Biphenyl derivatives as 5ht1d antagonists

1976
- 1976-08-18 MX MX367276U patent/MX3756E/es unknown
- 1976-08-18 CH CH1054476A patent/CH622005A5/de not_active IP Right Cessation
- 1976-08-19 NL NL7609208A patent/NL7609208A/xx not_active Application Discontinuation
- 1976-08-19 CS CS540676A patent/CS189026B2/cs unknown
- 1976-08-20 AR AR26441876A patent/AR210153A1/es active

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995026328A1 (en) *	1994-03-26	1995-10-05	Smithkline Beecham Plc	Biphenyl derivatives as 5ht1d antagonists

Also Published As

Publication number	Publication date
NL7609208A (nl)	1977-02-22
CS189026B2 (en)	1979-03-30
AR210153A1 (es)	1977-06-30
MX3756E (es)	1981-06-22

Legal Events

Date	Code	Title	Description
1983-04-29	PL	Patent ceased
2024-10-31	PL	Patent ceased

Publication	Publication Date	Title
EP0026848B1 (de)	1983-05-04	Tetralinderivate, ihre Herstellung und Heilmittel, welche diese Verbindungen enthalten
DE2128375C3 (de)	1982-05-13	Basische substituierte Alkylidenamino-oxyalkyl-carbonsäureester, deren Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE949105C (de)	1956-09-13	Verfahren zur Herstellung von neuen, fungiciden und protozoociden aromatischen Aminoketonen und deren Salzen
DE1695131A1 (de)	1970-12-10	Verfahren zur Herstellung von Imidazolderivaten
DE2616484C3 (de)	1981-02-26	Basische Benzoyläther, deren Salze und quartäre Ammoniumverbindungen sowie Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
CH622005A5 (en)	1981-03-13	Process for the preparation of novel benzanilide derivatives
DE1931061A1 (de)	1970-01-08	Pyrazolverbindungen,Verfahren zu ihrer Herstellung und ihre Verwendung
DE2307707A1 (de)	1973-08-23	Acetonylindolderivate, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
AT331215B (de)	1976-08-10	Verfahren zur herstellung von neuen aminobenzylaminen sowie deren saureadditionssalzen
AT400146B (de)	1995-10-25	Verfahren zur herstellung von 1-(2-((5-
AT314530B (de)	1974-04-10	Verfahren zur Herstellung von neuen 5- bzw. 4-Nitroimidazolderivaten und ihren Salzen
AT238185B (de)	1965-01-25	Verfahren zur Herstellung neuer 1-Methyl-pyrrolidinverbindungen
AT237599B (de)	1964-12-28	Verfahren zur Herstellung von neuen Aminen, sowie deren Säureadditionssalzen
AT336592B (de)	1977-05-10	Verfahren zur herstellung neuer 3-(4- biphenylyl)-buttersauren, deren estern, amiden und salzen
AT295516B (de)	1972-01-10	Verfahren zur Herstellung neuer cyclischer Amidine und ihrer Salze
AT206439B (de)	1959-11-25	Verfahren zur Herstellung von neuen, racemischen oder optisch aktiven Piperidyl-(2)-arylmethanoläthern
AT283362B (de)	1970-08-10	Verfahren zur Herstellung neuer Zimtsäureamide
AT330190B (de)	1976-06-25	Verfahren zur herstellung von neuen 1-(3- (5,6,7,8-tetrahydronaphth-1-yl-oxy) -propyl)-piperazin-derivaten und deren salzen
AT278808B (de)	1970-02-10	Verfahren zur Herstellung neuer 4-Acyl-3,4-dihydro-2(1H)-chinoxalinonderivate
AT266075B (de)	1968-11-11	Verfahren zur Herstellung von neuen Sulfonaniliden und deren Säureadditions- und Metallsalzen
AT370406B (de)	1983-03-25	Verfahren zur herstellung neuer allylaminderivate und ihrer saeureadditionssalze
CH615422A5 (cs)	1980-01-31
AT244933B (de)	1966-02-10	Verfahren zur Herstellung von neuen 1, 5-Diphenyl-3-azapentanolen-(1) und ihren Säureadditionssalzen
AT248416B (de)	1966-07-25	Verfahren zur Herstellung von neuen substituierten Hydrazinverbindungen und deren Salzen
CH628021A5 (en)	1982-02-15	Process for the preparation of 3-amino-2-hydroxypropoxy derivatives

CH622005A5 - Process for the preparation of novel benzanilide derivatives - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (2)

Publications (1)

Family

ID=26441220

Family Applications (1)

Country Status (5)

Cited By (1)

Cited By (1)

Also Published As

Similar Documents

Legal Events